BNZI - Why Arcutis Biotherapeutics Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket | Benzinga
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) rose sharply in pre-market trading after the FDA approved company’s ZORYVE topical foam, 0.3% for the treatment of seborrheic dermatitis in individuals aged 9 years and older.
Arcutis Biotherapeutics shares gained 25.3% to $3.06 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Gainers
- Banzai International, Inc. (NASDAQ: BNZI) shares gained 120.8% to $13.60 in pre-market trading. The company completed business combination with 7GC & Co on Friday.
- Royalty Management Holding Corporation (NASDAQ: RMCO) gained 39.8% to $3.51 in pre-market trading after falling around 20% on Friday.
- Wheeler Real Estate Investment Trust, Inc. (NASDAQ: WHLR) shares gained 45.8% to $0.3282 in pre-market trading after dipping around 24% on Friday.
- iCoreConnect Inc. (NASDAQ: ICCT) shares climbed 32.4% to $2.25 in pre-market trading after surging over 73% ...